To further demonstrate that the resolution of inflammation through EphrinB2-driven cardiac lymphangiogenesis provides an effective strategy to protect hearts against MI, we generated Lyve1 knockout (Lyve1−/−) mice (Supplementary Fig. 8a). The gene discussed is LYVE1; the disease is myocardial infarction.